Tender Details

Country: Germany
Summary: Conclusion of Non-Exclusive Drug Discount Agreements According to § 130A Para. 8 Sgb V by Means of a So-Called Open House Model for the Active Substance Ranolazine (Atc Code Who: C01eb18)
DET Ref No: 80286286
Deadline: 30 Apr 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: 154111-2023
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
The subject of this publication is the conclusion of non-exclusive discount agreements in accordance with Section 130a (8) SGB V for medicinal products containing the active ingredient ranolazine (ATC code according to WHO: C01EB18). The contract is concluded as part of a so-called open-house model, i. H. a contract is imminentopen to all interested pharmaceutical companies beyond the participation period, provided they meet and accept the participation requirements. As a result, individual contract negotiations are not conducted and (delivery) exclusivity does not exist. It will depend on itpointed out that the purchase quantity is unknown, as this depends on demand and the development of the number of insured persons, on the prescription behavior of doctors and on the dispensing and stocking behavior of public pharmacies. Accordingly, minimum purchase quantities are not guaranteedert. For more information, please refer to point II.2.4) of the notice.
Doc Title: Pharmaceutical products
Contract Type: Supplies
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Conclusion of Non-Exclusive Drug Discount Agreements According to § 130A Para. 8 Sgb V by Means of a So-Called Open House Model for the Active Substance Ranolazine (Atc Code Who: C01eb18) - Germany Tender

The AOK PLUS - THE HEALTH INSURANCE FUND FOR SAXONY AND THURINGIA, a Government sector organization in Germany, has announced a new tender for Conclusion of Non-Exclusive Drug Discount Agreements According to § 130A Para. 8 Sgb V by Means of a So-Called Open House Model for the Active Substance Ranolazine (Atc Code Who: C01eb18). This tender is published on GermanyTenders under DET Ref No: 80286286 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-04-30.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.